COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,609 Articles (22,913 medRxiv, 8,696 bioRxiv)

Most recent first Previous |  Page 2055: Articles 20541-20550  | Next

A Neutralizing Antibody-Conjugated Photothermal Nanoparticle Captures and Inactivates SARS-CoV-2
Cai, X., Prominski, A., Lin, Y., Ankenbruck, N., Rosenberg, J., Chen, M., Shi, J., Chang, E. B., Penaloza-MacMaster, P., Tian, B., Huang, J.
10.1101/2020.11.30.404624 — Posted: 2020-11-30
Characterization of SARS-CoV-2 N protein reveals multiple functional consequences of the C-terminal domain
Wu, C., Qavi, A. J., Hachim, A., Kavian, N., Cole, A. R., Moyle, A. B., Wagner, N. D., Sweeney-Gibbons, J., Rohrs, H. W., Gross, M. L., Peiris, J. S. M., Basler, C. F., Farnsworth, C. W., Valkenburg, S. A., Amarasinghe, G. K., Leung, D. W.
10.1101/2020.11.30.404905 — Posted: 2020-11-30
pH Effect on the Dynamics of SARS-CoV-2 Main Protease (Mpro)
Sharma, S., Deep, S.
10.1101/2020.11.30.404384 — Posted: 2020-11-30
Emetine as an antiviral agent suppresses SARS-CoV-2 replication by inhibiting interaction of viral mRNA with eIF4E: An in vitro study
Kumar, R., Khandelwal, N., Chander, Y., Riyesh, T., Gulati, B. R., Pal, Y., Tripathi, B. N., Barua, S., Kumar, N.
10.1101/2020.11.29.401984 — Posted: 2020-11-30
A Novel SARS-CoV-2 Multitope Protein/Peptide Vaccine Candidate is Highly Immunogenic and Prevents Lung Infection in an Adeno Associated Virus Human Angiotensin-Converting Enzyme 2 (AAV hACE2) Mouse Model
Guirakhoo, F., Kuo, L., Peng, J., Huang, J. H., Kuo, B., Lin, F., Liu, K., Liu, Z., Wu, G., Ding, S., Hou, L.-L., Cheng, J., Yang, V., Jiang, H., Wang, J., Chen, T., Xia, W., Lin, E., Hung, C. H., Chen, K., Shih, Z., Lin, Y., Schurter, B. T., Hu, M. M., Heppner, G., Malherbe, D. C., Bukreyev, A., Hellerstein, M., Monath, T., Wang, C. Y.
10.1101/2020.11.30.399154 — Posted: 2020-11-30
Multi-parameter formulation development for an HIV-vaccine protein with direct validation of epitope binding integrity and stoichiometry
Popp, C., Schramm, P., Wagner, R., Peterhoff, D., Battle, C., Kleusch, C., Plach, M. G.
10.1101/2020.11.30.403873 — Posted: 2020-11-30
Recombinant Fc-fusion vaccine of RBD induced protection against SARS-CoV-2 in non-human primate and mice
Sun, Y., Han, G., Wei, W., Hu, Z., Sun, S., He, L., Zhao, Z., Gu, H., Wang, T., Yang, X., Chen, S., Deng, Y., Li, J., Zhao, J., Li, L., Li, X., He, P., Li, G., Li, H., Gao, C., Lang, X., Geng, S., Wang, X., Fei, G., Li, Y., Gao, Y., Fang, X., Zhao, Y.
10.1101/2020.11.29.402339 — Posted: 2020-11-30
First computational design of Covid-19 coronavirus vaccine using lambda superstrings
Martinez, L., Malaina, I., Salcines, D., Teran, H., Alegre, S., MartInez de la Fuente, I., Gonzalez, E., Ocejo, G., Alvarez, C.
10.1101/2020.11.30.403824 — Posted: 2020-11-30
The impact of COVID-19 disruption to cervical cancer screening in England on excess diagnoses.
Castanon, A., Rebolj, M., Pesola, F., Sasieni, P.
10.1101/2020.11.30.20240754 — Posted: 2020-11-30
A psychrometric model to predict the biological decay of the SARS-CoV-2 virus in aerosols
Beggs, C. B., Avital, E. J.
10.1101/2020.11.29.20240408 — Posted: 2020-11-30

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).